InvestorsHub Logo
Followers 9
Posts 450
Boards Moderated 0
Alias Born 09/29/2011

Re: None

Wednesday, 02/20/2019 3:08:28 AM

Wednesday, February 20, 2019 3:08:28 AM

Post# of 689139
A Second-Generation Dendritic Cell Cancer Vaccine Preparing to Shine
DCVax-L efficacy may correlate with tumor mutational burden, suggesting mechanism is operable Carlo Rago, PhD

July - November 12 th 2018
Updated February 18 th 2019


https://www.scribd.com/document/393282167/A-Second-Generation-Dendritic-Cell-Cancer-Vaccine-Preparing-to-Shine
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News